Even though we have many advances in the development of oral hypoglycemic agents, an ideal drug for treating type 2 diabetes is still a distant reality. Today, physicians can choose from a variety of medications targeting numerous facets of disease, but each drug class poses some limitations. The age-old molecules, such as sulfonylureas and biguanides, are still valued because of their well-studied mode of action, safety, tolerability, and predictable pharmacodynamic effects. This book attempts to describe the historical aspects and advances in the arena of oral hypoglycemic agents, extended- and sustained-release formulations of glipizide and metformin (both of which have great promise in the treatment of type 2 diabetes mellitus) as well as evaluates the role of the group in diabetic foot infections. Oral Hypoglycemic Agents: Historical Perspectives and Current Trends Emerging and Future Concepts of Oral Hypoglycemic Agents Metformin: An Old Drug Rediscovered Oral Hypoglycemic Agents and Diabetic Foot Other Books in This Series
Más de 200 Películas que no Deberías Ver antes de Morir
Crónicas de Jerusalén
La Bipolaridad del Chocolate: Balanda de Una Fregona 02
Zatoichi